SCHEMBL27485249

SCHEMBL27485249

COC(=O)Cc1cccc(NC(=O)c2cccc(N)c2Cc2ccncc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.47
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ KDR P35968 4/20 0.46
▸ LMNA P02545 6/20 0.44
▸ HTT P42858 5/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ NPSR1 Q6W5P4 3/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ ROCK2 O75116 1/20 0.44
▸ GAA P10253 2/20 0.43
▸ KMT2A Q03164 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ PPARD Q03181 1/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27485938 0.86 PRKCI (0.53) MAPTSMN1; SMN2KDRLMNACYP17A1
SCHEMBL27484538 0.84 CYP17A1 (0.56) MAPTSMN1; SMN2KDRLMNAHTT
SCHEMBL27468045 0.83 KDR (0.44) MAPTSMN1; SMN2KDRLMNAHTT
SCHEMBL27486254 0.82 SMN1; SMN2 (0.53) MAPTSMN1; SMN2KDRLMNAHTT
SCHEMBL27548625 0.82 KDR (0.59) MAPTSMN1; SMN2KDRALDH1A1KMT2A
SCHEMBL27465575 0.82 P2RX1 (0.50) MAPTSMN1; SMN2KDRLMNAHTT
SCHEMBL27519714 0.81 MEN1 (0.51) MAPTSMN1; SMN2KDRLMNAALDH1A1
SCHEMBL27508410 0.81 KCNK3 (0.45) MAPTSMN1; SMN2KDRLMNAALDH1A1
SCHEMBL27466657 0.79 PTGS1 (0.64) KDRGAAKMT2AMAPK1
SCHEMBL27485596 0.79 KCNK3 (0.49) MAPTSMN1; SMN2KDRLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback